SUMMARY

LI-Hybrid 12 days per month on-site

Location: London, United Kingdom & Barcelona, Spain
Are you ready to shape the global medical voice across the asset lifecycle? Our Global Medical Affairs team is at the forefront of enterprise-wide medical leadership, driving strategy across therapeutic areas and ensuring a unified international and U.S. medical perspective. We lead the development and ownership of Integrated Evidence Packages (IEPs), guiding innovative evidence generation through interventional studies, non-interventional studies (NIS), real-world evidence (RWE), and implementation science projects.
This is a unique opportunity to bring your deep expertise in drug development and scientific strategy to some of the most complex and high-impact programs in the industry. You’ll act as a subject matter expert, influencing design and execution across disease areas, and providing strategic leadership in collaboration with NIBR, Development, and Medical Affairs teams globally. If you’re passionate about advancing medical innovation and thrive in high-stakes, cross-functional environments—this role is for you.

ESSENTIAL REQUIREMENTS:

• Fluent oral and written English.
• PhD/PharmD in Health Sciences. Specialist Degree or specialist qualification related to discipline for which you will be responsible is an advantage.
• Experience in Pharmaceutical Industry experience in Medical Affairs and/or Clinical Development.
• Strategic mindset and able to establish credibility and influence across a range of diverse stakeholders in a matrix organization to drive change.
• Deep understanding of health care systems and key external stakeholders.
• Strong track record of delivery focus for time and quality in medical affairs projects.
• Understands unmet medical needs, generates the right evidence to fulfil them, uses innovative, multichannel communication formats for effective evidence dissemination.
• Firm working knowledge of GCP, scientific and clinical methodology, protocol designs, management and regulatory requirements for clinical studies designated for review by regulatory authorities.

KEY RESPONSIBILITIES:

• Lead development and execution of medical affairs strategy for Asset priority programs, including transformative tactics such as research/population health, innovative partnerships, and integrated evidence plans.
• Co-develop plans for evidence generation, MSL / Field Medical Affairs strategy, medical education programs, scientific publication planning, and Medical Expert network development.
• Co-own the development and implementation of innovative education and scientific communication plans for external stakeholders.
• Track financials to ensure timely and cost-effective development and execution of medical activities.
• Prepare SRC submissions for TA assets within remit.
• Partner with Development, US and International cross-functional teams to shape the portfolio early and diversify evidence to achieve broad access at launch and enhance impact on clinical practice for priority programs.
• Represent Global Medical Affairs around prioritized portfolio with internal and external audiences, in collaboration with TAs, including the investment, medical and regulatory communities, as well as pharmaceutical or biotechnology industry collaborators/partners.
• Advocate for “the voice of the patient” internally and evaluate factors relevant to a patient’s informed decision-making.
• Provide direction and input into the development and implementation of successful reimbursement and market-access strategies.
• Contribute proactive input to Development on potential new therapeutic indications to enrich Registration Programs and explore new therapeutic opportunities.